A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
On Dec. 20, the FDA announced that the agency has approved Eli Lilly's ... in adults with obesity. The drug is to be paired with a reduced-calorie diet and increased physical activity, the ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
It should be used with a reduced-calorie diet and ... the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is ...